Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

Jun 5

1 min read

Following induction treatment for high-risk neuroblastoma, more than half of children experience cisplatin-induced hearing loss (CIHL), according to research published in JCO Clinical Advances.

1 Comment

lecteureoxafi

Aug 26

Check out our latest guide for some awesome tips to level up your site today. We hope these simple tricks help you succeed!

Like

Unexpected discovery points to a possible route for childhood brain tumor treatments

Recent Posts

Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

1 Comment

Unexpected discovery points to a possible route for childhood brain tumor treatments

Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Hodgkin Lymphoma Survivors Face Higher Long-Term Mortality

Emotional health supports physical health in survivors of childhood cancer

Hidden aggressive cells reveal why some lower-risk childhood cancers turn deadly

Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses

Protective drug dexrazoxane reduces heart damage in pediatric cancer survivors years after treatment ends

MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia

Archive

Search By Tags